Filgrastim therapy should be discontinued if the ANC surpasses 10,000/mm3 after the chemotherapy induced ANC nadir has occurred. Doses of filgrastim that increase the ANC beyond 10,000/mm3 may not result in any additional clinical benefit and should be avoided. The maximum tolerated dose of Filgrastim (Ambigrast) has not been determined.